- Home
- LIXT vs EZGO Comparison
LIXT vs EZGO Comparison
Compare LIXT & EZGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIXT
- EZGO
- Stock Information
- Founded
- LIXT 2005
- EZGO 2014
- Country
- LIXT United States
- EZGO China
- Employees
- LIXT N/A
- EZGO N/A
- Industry
- LIXT Biotechnology: Pharmaceutical Preparations
- EZGO Motor Vehicles
- Sector
- LIXT Health Care
- EZGO Consumer Discretionary
- Exchange
- LIXT Nasdaq
- EZGO Nasdaq
- Market Cap
- LIXT 2.2M
- EZGO 1.8M
- IPO Year
- LIXT N/A
- EZGO 2021
- Fundamental
- Price
- LIXT $4.00
- EZGO $0.34
- Analyst Decision
- LIXT
- EZGO
- Analyst Count
- LIXT 0
- EZGO 0
- Target Price
- LIXT N/A
- EZGO N/A
- AVG Volume (30 Days)
- LIXT 6.2M
- EZGO 385.7K
- Earning Date
- LIXT 08-07-2025
- EZGO 07-01-2025
- Dividend Yield
- LIXT N/A
- EZGO N/A
- EPS Growth
- LIXT N/A
- EZGO N/A
- EPS
- LIXT N/A
- EZGO N/A
- Revenue
- LIXT N/A
- EZGO $20,895,830.00
- Revenue This Year
- LIXT N/A
- EZGO N/A
- Revenue Next Year
- LIXT N/A
- EZGO N/A
- P/E Ratio
- LIXT N/A
- EZGO N/A
- Revenue Growth
- LIXT N/A
- EZGO 18.98
- 52 Week Low
- LIXT $0.64
- EZGO $0.29
- 52 Week High
- LIXT $4.45
- EZGO $1.91
- Technical
- Relative Strength Index (RSI)
- LIXT 80.89
- EZGO 51.31
- Support Level
- LIXT $2.02
- EZGO $0.31
- Resistance Level
- LIXT $4.25
- EZGO $0.35
- Average True Range (ATR)
- LIXT 0.54
- EZGO 0.03
- MACD
- LIXT 0.30
- EZGO 0.00
- Stochastic Oscillator
- LIXT 96.99
- EZGO 84.26
About LIXT Lixte Biotechnology Holdings Inc.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
About EZGO EZGO Technologies Ltd.
EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.